Ole S. S.
- Country
- Denmark
- Department
- Department of Infectious Diseases
Research Overview
- A Phase I Dose-Escalation Study to Evaluate the Safety and Efficacy of Anti-Hepatitis B Antibodies in Patients with Chronic Hepatitis B Infection
- Evaluation of Antiretroviral Therapy Combined with 10-1074-LS and Teropavimab in Primary or Early HIV Infection: A Randomized, Placebo-Controlled Trial
- Dose-Escalation Study on the Safety and Efficacy of Anti-Hepatitis B Antibodies in Patients with Chronic Hepatitis B Infection
Data & Insights
Has run more than one trial at 2 of 12 partner sites.
Specializations
Infectious Diseases
The investigator specializes in the treatment and management of viral infections, with particular emphasis on HIV and chronic hepatitis B.
- HIV Treatment Innovation
- Hepatitis B Management
- Viral Immunology
The investigator explores novel therapeutic approaches using antibody-based treatments for chronic viral conditions.
Immunotherapy Research
A core focus involves investigating broad neutralizing antibodies and their therapeutic applications in viral diseases.
- Antibody-Based Therapeutics
- Immune Response Modulation
- Viral Suppression Strategies
The research encompasses innovative approaches to virological control through immunological interventions.
Clinical Applications
The investigator conducts research on ascending dose studies to evaluate novel therapeutic approaches.
- Treatment Safety Assessment
- Therapeutic Efficacy Studies
- Drug Response Monitoring
Focus includes evaluating the safety and effectiveness of new therapeutic antibodies in chronic viral infections.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.